Send to

Choose Destination
J Pediatr Hematol Oncol. 2015 Jan;37(1):63-7. doi: 10.1097/MPH.0000000000000261.

Vulvar fibromatosis: a clinical enigma.

Author information

*Obstetrics & Gynecology Department at Montefiore Departments of †Gynecologic and Oncology ‡Pathology §Pediatric Hematology-Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY.



To present a case of recurrent vulvar fibromatosis in an adolescent, discuss the specific difficulties of treating adolescents, and review the literature on available treatment.


We present a case of recurrent vulvar fibromatosis in a 14-year-old girl, requiring several treatment modalities, including multiple surgeries, radiation therapy, and multiagent chemotherapy. We then discuss management strategies for these tumor types, and specifically examine how tumor location may impact their treatment.


Vulvar desmoids are extremely uncommon and they can be disfiguring and cause significant discomfort for women. Initial management of these tumors is surgical excision, yet failed surgery is often followed by other treatment modalities, including radiation, tyrosine kinase inhibitors, nonsteroidal anti-inflammatory drugs, hormonal therapy, and chemotherapy. This case clearly highlights the difficulties in managing these rare tumors, particularly in the adolescent population.


Desmoid tumors are nonmalignant, locally aggressive neoplasms most common in the 15 to 60 years age group. They are associated with high estrogen states, prior surgical trauma, and Gardner syndrome. Most commonly, desmoid tumors present in the abdominal wall, shoulder, neck, and chest, but can occur anywhere in the body. Given their rarity and lack of definitive therapy, vulvar desmoid tumors can be exceedingly difficult to treat, and are best managed with an interdisciplinary approach.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for NYU School of Medicine
Loading ...
Support Center